Pantrone Consulting Co. Ltd. was established in 2019 and is a Contract Research Organization (CRO) specializing in cell therapy clinical trials. Pantrone is composed of a team of top-notch doctoral and master’s graduates from domestic and international universities.
Pantrone has successfully obtained multiple approvals for Investigational New Drug (IND) applications from the U.S. Food and Drug Administration (FDA), including the first Taiwan-based allogeneic chimeric antigen receptor T-cell (Car-T) therapy to receive IND approval in the United States. We provide the most professional services for clinical trials of cell products, and we believe Pantrone is your best choice for developing cell products.
